diammine(1,1- cyclobutanedicarboxylate)platinum(II)

01/01/2012 - "In this study, we investigated the anticancer activity of dicycloplatin in cancer cells and signaling pathways involved in dicycloplatin-induced apoptosis. "
08/01/2019 - "Cystoscopy surveillance of the first American cancer patient treated with dicycloplatin was performed quarterly. "
01/01/2012 - "Dicycloplatin inhibited the proliferation of cancer cells and increased the percentage of apoptosis in a concentration-dependent manner. "
03/01/2022 - "First American Cancer Patient to Receive Dicycloplatin (DCP) Chemotherapy Achieves Remission After Seven Weeks of DCP Capsules - A Case Report."
04/21/2015 - "Dicycloplatin is a new generation supramolecular platinum-containing anti-cancer drug. "

08/29/2014 - "The aim of this study was to compare the efficacy and toxicity of dicycloplatin plus paclitaxel with those of carboplatin plus paclitaxel as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC). "

03/01/2022 - "Intravenous (IV) dicycloplatin (DCP) sustained remission in an American bladder cancer patient for five years. "

08/29/2014 - "In this study, 240 NSCLC patients with stage IIIB (with pleural effusion) and stage IV disease were randomly assigned (1: 1) to receive dicycloplatin 450 mg/m(2) or carboplatin AUC = 5, in combination with paclitaxel 175 mg/m(2) (D + P or C + P) every 3 weeks for up to 4 to 6 cycles. "

08/29/2014 - "A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancers."